1. Copyright © 2014 American Medical Association. All rights reserved.
From: Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 AdjuvantA Randomized Clinical Trial
JAMA. 2014;312(14): doi: /jama
Figure Legend:
Flow of Patients in Influenza A/Shanghai/2/13 (H7N9) Inactivated Virus Vaccine Trial
Date of download: 10/31/2017
Copyright © 2014 American Medical Association. All rights reserved.

2. Copyright © 2014 American Medical Association. All rights reserved.
From: Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 AdjuvantA Randomized Clinical Trial
JAMA. 2014;312(14): doi: /jama
Figure Legend:
Reverse Cumulative Distribution Curves for Day 42 Hemagglutination Inhibition and Neutralizing Antibody ResponsesMF59 adjuvant enhances hemagglutination inhibition and neutralizing antibody responses. H7N9 indicates influenza A/Shanghai/2/13.
Date of download: 10/31/2017
Copyright © 2014 American Medical Association. All rights reserved.

3. Copyright © 2014 American Medical Association. All rights reserved.
From: Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 AdjuvantA Randomized Clinical Trial
JAMA. 2014;312(14): doi: /jama
Figure Legend:
Association of Antibody Response With Prior Receipt of Seasonal Influenza Vaccine
Date of download: 10/31/2017
Copyright © 2014 American Medical Association. All rights reserved.

4. Copyright © 2014 American Medical Association. All rights reserved.
From: Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 AdjuvantA Randomized Clinical Trial
JAMA. 2014;312(14): doi: /jama
Figure Legend:
Association of Antibody Response With AgeThe numbers of participants are from vaccination day 0. GMT indicates geometric mean titer; H7N9, influenza A/Shanghai/2/13.
Date of download: 10/31/2017
Copyright © 2014 American Medical Association. All rights reserved.